Evaluation of chest pain and heart failure in the emergency department: impact of multimarker strategies and B-type natriuretic peptide.
In the emergency setting, acute chest pain and shortness of breath represent common patient presentations. Cardiac biomarkers including myoglobin, creatine kinase (CK)-MB, troponin, and b-type natriuretic peptide provide diagnostic and prognostic information for patients with chest pain and shortness of breath. This article reviews the use of cardiac biomarkers in the emergency department to evaluate acute coronary syndrome and congestive heart failure.
Gibler
W Brian
WB
Department of Emergency Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
Blomkalns
Andra L
AL
Collins
Sean P
SP
D000208:Acute Disease; D015415:Biomarkers / Q000097:blood; D002637:Chest Pain / Q000175:diagnosis* / Q000628:therapy; D003327:Coronary Disease / Q000175:diagnosis / Q000628:therapy; D003402:Creatine Kinase / Q000097:blood; D052279:Creatine Kinase, MB Form; D004632:Emergency Medical Services; D006333:Heart Failure / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D007527:Isoenzymes / Q000097:blood; D020097:Natriuretic Peptide, Brain / Q000097:blood; D013577:Syndrome; D014336:Troponin / Q000097:blood; D014481:United States / Q000453:epidemiology
D015415:Biomarkers; D007527:Isoenzymes; D014336:Troponin; D020097:Natriuretic Peptide, Brain; D003402:Creatine Kinase; D052279:Creatine Kinase, MB Form